FIELD: pharmaceutical chemistry, medicine.
SUBSTANCE: in the suggested composition one should apply heptapeptide of Met-Glu-His-Phe-Pro-Gly-Pro sequence (heptapeptide A) for treating ischemic insult due to introducing 2 drops of compositions into each nasal canal 5-6 times daily for 10 d at disease of average severity degree, and in case of severe degree - per 3 drops of the present composition into each nasal canal 7 times daily for 10 d. The present innovation provides increased efficiency at decreased concentration of heptapeptide without any side effects.
EFFECT: higher efficiency of therapy.
2 cl, 6 dwg, 8 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
METHOD FOR TREATING THE CASES OF ISCHEMIC INSULT | 1997 |
|
RU2124365C1 |
NOOTROPIC DRUG AND PHARMACEUTICAL NOOTROPIC COMPOSITION | 1994 |
|
RU2045958C1 |
METHOD FOR TREATMENT OF NERVOUS SYSTEM DISORDER IN CHILDREN OF YOUNGEST AGE AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2241487C1 |
AGENT AND METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE | 2008 |
|
RU2384343C2 |
USING PREPARATION "SEMAX" AS MEANS OF ACTIVATION OF ADAPTIVE IMMUNITY | 2015 |
|
RU2584234C1 |
USE OF PEPTIDE Met-Glu-His-Phe-Pro-Gly-Pro (Semax) FOR DYSBIOSIS CORRECTION IN CHRONIC IMMOBILIZATION STRESS | 2019 |
|
RU2709527C1 |
METHOD OF TREATING ACUTE ISCHEMIC AND HEMORRHAGIC CEREBROVASCULAR DISEASE | 2010 |
|
RU2477637C2 |
USE OF PEPTIDE ACTH (4-7) -PGP OF HEPATOPROTECTIVE ACTION | 2013 |
|
RU2528741C1 |
METHOD OF SCREENING PHARMACOLOGICAL COMPOUNDS ACCORDING TO NEUROPROTECTIVE ACTIVITY | 2009 |
|
RU2383615C1 |
Authors
Dates
2005-05-10—Published
2002-12-30—Filed